Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : T.ITE: iTech Capital (TSE) -- Ignore unavailable to you. Want to Upgrade?

To: mr. campbell who wrote (4551)	3/26/2000 8:58:00 PM
From: Keith Minler	Read Replies (2) \| Respond to of 5053

Hi All; I spoke to Jim Graham last week, just before the Staudt interview. He was really upbeat and confirmed that they will get the story out. He went on to justify further price increases by speculating that they could earn as much as a 10 fold increase on their initial investments, and then they would only need another 7 fold return to have a billion dollar company. (He was talking U.S.$, $14,000,000 times 10 times 7 equals $980,000,000 or about $28 per share U.S.) I said that sounded too good to be true and he replied that if you buy 'wholesale' (i.e. pre-IPO) these are the types of return to expect. He also said that they would be doing a financing this year and sooner rather than later. I took that to be a statement of a goal to be achieved rather than a promise. Still it implies a financing before September. It is interesting to extrapolate as to what that financing could do.Optimistically 5 Million shares at say $4.00 would raise $20,000,000. Plug that into the 10 times base times seven return and you end up with a share price of about $59 U.S. That would be a couple of years out minimum given share restrictions and the fact not all companies would rush to IPO. I also asked him if they would consider an alliance with a partner with expertise in the Biotech field. He said no, they would prefer to keep a sharp focus on B2B and telecom sectors. If a great Bio deal came their way they would none-the-less take a look at it. I'll probably make the annual meeting, good lord willing and if the creeks don't rise. I may consider broaching the subject of issuing rights to existing shareholders at the time of the next financing. Later Keith